Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
J Vadakekolathu, S Rutella - Blood, 2024 - ashpublications.org
Single-cell and spatial multimodal technologies have propelled discoveries of the solid
tumor microenvironment (TME) molecular features and their correlation with clinical …
tumor microenvironment (TME) molecular features and their correlation with clinical …
A membrane-associated MHC-I inhibitory axis for cancer immune evasion
Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such
as acute myeloid leukemia (AML), do not respond or develop resistance. A potential mode of …
as acute myeloid leukemia (AML), do not respond or develop resistance. A potential mode of …
[HTML][HTML] A new genomic framework to categorize pediatric acute myeloid leukemia
Recent studies on pediatric acute myeloid leukemia (pAML) have revealed pediatric-specific
driver alterations, many of which are underrepresented in the current classification schemas …
driver alterations, many of which are underrepresented in the current classification schemas …
[HTML][HTML] Obesity and leukemia: biological mechanisms, perspectives, and challenges
D Tsilingiris, NG Vallianou, N Spyrou… - Current Obesity …, 2024 - Springer
Abstract Purpose of Review To examine the epidemiological data on obesity and leukemia;
evaluate the effect of obesity on leukemia outcomes in childhood acute lymphoblastic …
evaluate the effect of obesity on leukemia outcomes in childhood acute lymphoblastic …
[HTML][HTML] An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors
Abstract Analysis of the human hematopoietic progenitor compartment is being transformed
by single-cell multimodal approaches. Cellular indexing of transcriptomes and epitopes by …
by single-cell multimodal approaches. Cellular indexing of transcriptomes and epitopes by …
[HTML][HTML] Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche
DW Chen, JM Fan, JM Schrey, DV Mitchell, SK Jung… - Leukemia, 2024 - nature.com
Inflammation in the bone marrow (BM) microenvironment is a constitutive component of
leukemogenesis in acute myeloid leukemia (AML). Current evidence suggests that both …
leukemogenesis in acute myeloid leukemia (AML). Current evidence suggests that both …
[HTML][HTML] Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
Interferon gamma (IFNγ) is a critical cytokine known for its diverse roles in immune
regulation, inflammation, and tumor surveillance. However, while IFNγ levels were elevated …
regulation, inflammation, and tumor surveillance. However, while IFNγ levels were elevated …
[HTML][HTML] A single-cell taxonomy predicts inflammatory niche remodeling to drive tissue failure and outcome in human AML
L Chen, E Pronk, C van Dijk, Y Bian, J Feyen… - Blood Cancer …, 2023 - AACR
Cancer initiation is orchestrated by an interplay between tumor-initiating cells and their
stromal/immune environment. Here, by adapted single-cell RNA sequencing, we decipher …
stromal/immune environment. Here, by adapted single-cell RNA sequencing, we decipher …
The role of inflammation in the initiation and progression of myeloid neoplasms
Myeloid malignancies are devastating hematologic cancers with limited therapeutic options.
Inflammation is emerging as a novel driver of myeloid malignancy, with important …
Inflammation is emerging as a novel driver of myeloid malignancy, with important …
[HTML][HTML] Inhibitory CARs fail to protect from immediate T cell cytotoxicity
MA Funk, G Heller, P Waidhofer-Söllner, J Leitner… - Molecular Therapy, 2024 - cell.com
Chimeric antigen receptors (CARs) equipped with an inhibitory signaling domain (iCARs)
have been proposed as strategy to increase on-tumor specificity of CAR-T cell therapies …
have been proposed as strategy to increase on-tumor specificity of CAR-T cell therapies …